Effects of kisspeptin on hormone secretion in humans.
Chan. Yee-Ming YM
Key Findings
- Brief kisspeptin exposure causes ~17 min of sustained GnRH release in men
- Women’s hormone response to kisspeptin varies across menstrual phases
- Continuous kisspeptin leads to desensitization, while intermittent dosing can stimulate hormone release
Practical Outcomes
- For biohackers, intermittent low‑dose kisspeptin could be used to temporarily boost LH/ testosterone or other sex hormones, whereas continuous dosing may blunt the system. Timing matters: men may benefit from short pulses, while women need to consider cycle phase. Any protocol should start low, monitor hormone levels, and avoid long‑term continuous exposure to prevent desensitization.
Summary
The study shows that short bursts of kisspeptin can trigger a lasting release of reproductive hormones, while constant exposure makes the body become less responsive. Men and women react differently, especially across the menstrual cycle, and the way kisspeptin is given (single dose vs continuous) can either boost or dampen hormone activity. This info helps people think about how to use kisspeptin if they want to tweak hormones for health or performance.
Abstract
Studies of the actions of kisspeptin in human subjects have examined the effects of different kisspeptin isoforms, doses, and routes of administration on LH secretion, a surrogate measure of GnRH release. These studies, in addition to detailing how these different variables affect LH secretion in response to kisspeptin, have produced new insights into kisspeptin physiology: (1) Brief exposure to kisspeptin results in sustained GnRH release lasting ~17 min in men. (2) Women in different phases of the menstrual cycle have differences in their response to kisspeptin, suggesting that endogenous kisspeptin secretion and GnRH neuronal responsiveness vary in response to the changing sex-steroid environment across the menstrual cycle. (3) Kisspeptin resets the GnRH pulse generator in men, but does not appear to do so in women. (4) Continuous exposure to kisspeptin results in desensitization to kisspeptin, and thus kisspeptin has the potential to either stimulate or suppress reproductive endocrine activity depending on the mode of administration. These findings pave the way for future studies using kisspeptin as a physiologic, diagnostic, and therapeutic tool in both healthy adults and in patients with reproductive disorders.
Study Information
pubmed
2013
10.1007/978-1-4614-6199-9_5
25
67